152 related articles for article (PubMed ID: 12917515)
1. Future strategies in the diagnosis, staging and treatment of bladder cancer.
van der Heijden AG; Witjes JA
Curr Opin Urol; 2003 Sep; 13(5):389-95. PubMed ID: 12917515
[TBL] [Abstract][Full Text] [Related]
2. 18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study.
Hitier-Berthault M; Ansquer C; Branchereau J; Renaudin K; Bodere F; Bouchot O; Rigaud J
Int J Urol; 2013 Aug; 20(8):788-96. PubMed ID: 23279605
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P
Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
[TBL] [Abstract][Full Text] [Related]
4. Imaging in Localized Bladder Cancer: Can Current Diagnostic Modalities Provide Accurate Local Tumor Staging?
Gurram S; Muthigi A; Egan J; Stamatakis L
Curr Urol Rep; 2019 Nov; 20(12):82. PubMed ID: 31781871
[TBL] [Abstract][Full Text] [Related]
5. Imaging bladder cancer.
Cowan NC; Crew JP
Curr Opin Urol; 2010 Sep; 20(5):409-13. PubMed ID: 20625298
[TBL] [Abstract][Full Text] [Related]
6. Bladder cancer. Advances in laboratory innovations and clinical management, with emphasis on innovations allowing bladder-sparing approaches for patients with invasive tumors.
Shipley WU; Prout GR; Kaufman DS
Cancer; 1990 Feb; 65(3 Suppl):675-83. PubMed ID: 2405994
[TBL] [Abstract][Full Text] [Related]
7. Treatment of invasive bladder cancer: lessons from the past and perspective for the future.
Tsukamoto T; Kitamura H; Takahashi A; Masumori N
Jpn J Clin Oncol; 2004 Jun; 34(6):295-306. PubMed ID: 15333680
[TBL] [Abstract][Full Text] [Related]
8. Review of metastatic bladder cancer.
Pagliaro LC; Sharma P
Minerva Urol Nefrol; 2006 Mar; 58(1):53-71. PubMed ID: 16760884
[TBL] [Abstract][Full Text] [Related]
9. Bladder cancer.
Barocas DA; Clark PE
Curr Opin Oncol; 2008 May; 20(3):307-14. PubMed ID: 18391631
[TBL] [Abstract][Full Text] [Related]
10. [Bladder cancer: realities and perspectives].
Chrétien Y; Oudard S; Durdux C
Bull Cancer; 2003 Jan; 90(1):61-7. PubMed ID: 12609806
[TBL] [Abstract][Full Text] [Related]
11. Bladder cancer.
Clark PE
Curr Opin Oncol; 2007 May; 19(3):241-7. PubMed ID: 17414643
[TBL] [Abstract][Full Text] [Related]
12. A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy.
Baumann BC; Guzzo TJ; He J; Keefe SM; Tucker K; Bekelman JE; Hwang WT; Vaughn DJ; Malkowicz SB; Christodouleas JP
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):81-8. PubMed ID: 22543204
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment of superficial bladder cancers].
Caremel R; Pfister C
Rev Prat; 2007 Mar; 57(6):621-7. PubMed ID: 17593786
[TBL] [Abstract][Full Text] [Related]
14. Bladder cancer.
Morgan TM; Clark PE
Curr Opin Oncol; 2010 May; 22(3):242-9. PubMed ID: 20150808
[TBL] [Abstract][Full Text] [Related]
15. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
Koga F; Fujii Y; Masuda H; Numao N; Yokoyama M; Ishioka J; Saito K; Kawakami S; Kihara K
BJU Int; 2012 Sep; 110(6 Pt B):E203-8. PubMed ID: 22289431
[TBL] [Abstract][Full Text] [Related]
16. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy.
Soloway MS; Lopez AE; Patel J; Lu Y
Cancer; 1994 Apr; 73(7):1926-31. PubMed ID: 8137219
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic work-up and treatment of bladder cancer: current developments].
Ohlmann CH; Stöckle M
Urologe A; 2010 Sep; 49 Suppl 1():172-7. PubMed ID: 20812047
[TBL] [Abstract][Full Text] [Related]
19. The economics of bladder cancer: costs and considerations of caring for this disease.
Svatek RS; Hollenbeck BK; Holmäng S; Lee R; Kim SP; Stenzl A; Lotan Y
Eur Urol; 2014 Aug; 66(2):253-62. PubMed ID: 24472711
[TBL] [Abstract][Full Text] [Related]
20. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.
Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W
Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
